[New trends in chemotherapy of systemic lupus erythematosus: treatment with mycophenolate mofetil].
The review covers current issues of pharmacotherapy of systemic lupus erythematosus (SLE) with a focus on a novel immunodepressant mofetil microphenolate (MM) which is not inferior in efficiency to a conventional anti-SLE drug cyclophosphamide which has a worse tolerance.
Shekshina
S V
SV
Kliukvina
N G
NG
Nasonov
E L
EL
Nasonova
V A
VA
D004358:Drug Therapy / Q000639:trends; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007291:Inosine Monophosphate / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*
D004791:Enzyme Inhibitors; D007291:Inosine Monophosphate; D009173:Mycophenolic Acid